Literature DB >> 16314828

Characterization of human hepatocytes isolated from non-transplantable livers.

Anna Łaba1, Alina Ostrowska, Dariusz Patrzałek, Leszek Paradowski, Andrzej Lange.   

Abstract

INTRODUCTION: The successful use of hepatocytes depends on a reliable demonstration of the functional and morphological integrity of isolated cells. Herein we investigated whether the isolation and cryopreservation of primary human hepatocytes can compromise cell viability and liver-specific characteristics. MATERIAL/
METHODS: Hepatocytes were isolated from encapsulated human liver segments by a modified 2-step perfusion technique. Isolated cells were Percoll-purified, cryopreserved, and stored in liquid nitrogen for 1-12 months. For rapid assessment of fresh and cryopreserve/thawed hepatocyte yield and viability, the cells were stained with trypan blue or labeled with fluorochromes. For immunocytochemical analysis, the cells were labeled with monoclonal antibodies for the presence of the following antigens and chemokines: CD3, CD45Ro, CD45Ra, CD34, CD68, CD90, CD95, CD20, HLA-DR, Ki67, PCNA, Bcl-2, p53, CXCR3, CXCR4, and SDF-1. The cells were tested for several specific functions, such as ureagenesis, energy status, MTT activity, lactate dehydrogenase leakage, and total CYP450 content.
RESULTS: Assessment of both freshly isolated (Percoll-purified) and cryopreserved/thawed hepatocytes revealed a low constitutive level of contamination by non-parenchymal cells compared with crude (unpurified) preparations and tissue sections. All viable hepatocytes showed intact morphology and retained CYP450 protein, energy status, and urea synthesis.
CONCLUSIONS: Modifications in hepatocyte preparations, such as depletion of dead, damaged, and nonparenchymal cells, improves cell purity, which can be adapted to further evaluation of hepatocyte immunogenicity. These data illustrate the importance and feasibility of human hepatocyte banking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314828

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  5 in total

1.  Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience.

Authors:  Ricky H Bhogal; James Hodson; David C Bartlett; Christopher J Weston; Stuart M Curbishley; Emma Haughton; Kevin T Williams; Gary M Reynolds; Phillip N Newsome; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

2.  Impact of Percoll purification on isolation of primary human hepatocytes.

Authors:  R Horner; J G M V Gassner; M Kluge; P Tang; S Lippert; K H Hillebrandt; S Moosburner; A Reutzel-Selke; J Pratschke; I M Sauer; N Raschzok
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

3.  All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells.

Authors:  Melanie Werner; Sabrina Driftmann; Kathrin Kleinehr; Gernot M Kaiser; Zotlan Mathé; Juergen-Walter Treckmann; Andreas Paul; Kathrin Skibbe; Joerg Timm; Ali Canbay; Guido Gerken; Joerg F Schlaak; Ruth Broering
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

4.  Hepatocyte isolation from unused/rejected livers for transplantation: initial step toward hepatocyte transplantation, the first experience from iran.

Authors:  Mahdokht Hossein Aghdaie; Bita Geramizadeh; Negar Azarpira; Elahe Esfandiari; Masoume Darai; Marjan Rahsaz; Saman Nikeghbalian; Seyed Ali Malekhosseini
Journal:  Hepat Mon       Date:  2013-08-03       Impact factor: 0.660

5.  Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver.

Authors:  David C Bartlett; James Hodson; Ricky H Bhogal; Janine Youster; Phil N Newsome
Journal:  Cytotherapy       Date:  2014-03-15       Impact factor: 5.414

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.